Doug Drysdale on Advancing Psychedelic Medicine for Mental Health Treatment

In this Mission Matters episode, Adam Torres interviews Doug Drysdale, CEO of Cybin, about the groundbreaking work his company is doing to develop psychedelic-based treatments for mental health conditions. From clinical trials to regulatory challenges, Doug shares his mission to transform suffering into healing through next-generation therapeutics.

Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.

Apply to be a guest on our podcast:

https://missionmatters.lpages.co/podcastguest/

Visit our website:

https://missionmatters.com/

More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices